If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPLF.L Regulatory News (MPLF)

  • There is currently no data for MPLF

Edison issues flash on Marble Point Loan Financing

15 Apr 2020 15:29

RNS Number : 7815J
Marble Point Loan Financing Limited
15 April 2020
 

 

London, UK, 15 April 2020

Edison issues flash on Marble Point Loan Financing (MPLF)

Marble Point Loan Financing (MPLF) is temporarily suspending its dividend due to the impact of COVID-19.The recent economic disruption has resulted in rating agencies downgrading the underlying collateral of MPLF's collateralised loan obligations (CLOs) at a pace that could trigger its need to make provisions. The heightened risk is above that modelled by MPLF and could affect cash flow. MPLF's policy is to maintain a well-funded dividend. In the last five quarters cash distributions have exceeded dividends by a good margin. With the total impact of COVID-19 uncertain, management believes it is prudent to preserve cash now, which will provide more flexibility for when dislocations in the credit market provide good investment opportunities.

 

At the end of February, MPLF's investment portfolio was $171.8m, of which 69% was in equity tranches of 10 different Marble Point CLO issues. The remaining portfolio was split between CLO debt tranches (9%), CLO fee participations (2.8%), the NAV of the funding subsidiary (11.2%) and the Marble Point loan accumulation facility (8%). It also had $2.9m in other assets. Subsequent to month end on 24 March, MPLF invested approximately $20m in the equity of MarblePoint CLO XVII. The equity tranches had an effective yield of 8.6%, the debt had an all-in yield of 3.7% and fee participations were 18.2%.

Click here to view the full report.

 

Subscribe to Edison's content to receive reports by email.

All reports published by Edison are free-to-access and available on the website.

 

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Pedro Fonseca, +44 (0)20 3077 5700

Milosz Papst, +48 71 32 32 665

investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group- 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAEALLSFAKEEFA
Date   Source Headline
23rd May 20227:00 amRNSNet Asset Value & Publication of Monthly Report
23rd May 20227:00 amRNS1st Quarter Results
22nd Apr 20224:36 pmRNSDividend Declaration
21st Apr 20227:00 amRNSNet Asset Value & Publication of Monthly Report
8th Apr 20225:09 pmRNSAnnual Financial Report
31st Mar 20226:00 pmRNSDividend Declaration
24th Mar 20227:00 amRNSNet Asset Value & Publication of Monthly Report
21st Feb 20227:00 amRNSNet Asset Value & Publication of Monthly Report
31st Jan 20223:25 pmRNSHolding(s) in Company
24th Jan 20227:00 amRNSNet Asset Value & Publication of Monthly Report
20th Jan 20225:33 pmRNSDividend Declaration
4th Jan 20227:00 amRNSDirector/PDMR Shareholding
29th Dec 20217:00 amRNSDividend Declaration
23rd Dec 20217:00 amRNSNet Asset Value & Publication of Monthly Report
24th Nov 20217:00 amRNS3rd Quarter Results
23rd Nov 20217:00 amRNSNet Asset Value & Publication of Monthly Report
19th Nov 20213:23 pmRNSResult of AGM
9th Nov 20215:21 pmRNSDirector/PDMR Shareholding
5th Nov 20217:00 amRNSNotice of AGM
3rd Nov 20214:25 pmRNSTransaction in Own Shares
27th Oct 20217:00 amRNSTransaction in Own Shares
21st Oct 20215:21 pmRNSDividend Declaration
21st Oct 20217:00 amRNSNet Asset Value & Publication of Monthly Report
12th Oct 20216:00 pmRNSShort Form Amalgamation Announcement
22nd Sep 20217:00 amRNSNet Asset Value & Publication of Monthly Report
17th Sep 20217:00 amRNSInvestment in Marble Point CLO XXI
14th Sep 20217:00 amRNSDividend Declaration
13th Sep 20216:00 pmRNSSHORT FORM AMALGAMATION ANNOUNCEMENT
13th Sep 20216:00 pmRNSHalf-year Report
8th Sep 20216:00 pmRNSDirector/PDMR Shareholding
25th Aug 20217:00 amRNSNet Asset Value & Publication of Monthly Report
6th Aug 20217:00 amRNSPublication of Key Investor Document
5th Aug 20217:00 amRNSInvestment in Marble Point CLO XXII
21st Jul 20216:00 pmRNSSterling Dividend Amount
20th Jul 20217:00 amRNSNet Asset Value & Publication of Monthly report
1st Jul 20217:00 amRNSDividend Declaration
1st Jul 20217:00 amRNSB Share Voting Rights
28th Jun 20216:00 pmRNSDirector/PDMR Shareholding
28th Jun 20216:00 pmRNSDirector/PDMR Shareholding
22nd Jun 20217:00 amRNSNet Asset Value & Publication of Monthly Report
14th Jun 20217:00 amRNSMP CLO VIII Reset Closing
1st Jun 20216:00 pmRNS1st Quarter Results
25th May 20217:00 amRNSInvestment in Marble Point CLO XX
24th May 20217:00 amRNSNet Asset Value & Publication of Monthly Report
23rd Apr 20217:00 amRNSNet Asset Value & Publication of Monthly Report
22nd Apr 20216:00 pmRNSSterling Dividend Amount
9th Apr 20216:00 pmRNSAnnual Financial Report
30th Mar 20217:00 amRNSDividend Declaration
24th Mar 20217:00 amRNSNet Asset Value & Publication of Monthly Report
26th Feb 20217:00 amRNSQ1 2021 Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.